• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Antitumor effect of neutrophil-derived TRAIL for oral squamous cell carcinoma

Research Project

  • PDF
Project/Area Number 21592562
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Surgical dentistry
Research InstitutionTsurumi University (2011)
Showa University (2009-2010)

Principal Investigator

IWASE Masayasu  鶴見大学, 歯学部, 非常勤講師 (50193743)

Project Period (FY) 2009 – 2011
KeywordsTRAIL / 好中球 / アポトーシス / 抗腫瘍効果
Research Abstract

BCG and OK432 enhanced TRAIL production and chemotaxis of neutrophils in a dose-dependent manner. Although TRAIL derived from neutrophils was insufficient cytotoxicity for squamous cell carcinoma cells, TRAIL from neutrophils possessed a priming effect for anti-tumor drugs or irradiation-induce cytotoxicity. These results are suggested that a combination of OK-432 and conventional therapy such as anti-tumor drugs and irradiation is a new anti-tumor strategy.

  • Research Products

    (2 results)

All 2011 2009

All Journal Article (1 results) Presentation (1 results)

  • [Journal Article] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis2011

    • Author(s)
      SAYAKA YOSHIBA, MASAYASU IWASE, SAYAKA TAKAOKA, MAKIKO UCHIDA, YUJI KURIHARA, HITOSGI WATANABE, SATORU SHINTANI
    • Journal Title

      Oncology Reports

      Volume: 25 Pages: 645-652

  • [Presentation] Enhanced susceptibility to TRAIL-mediated apoptosis in oral squamous cell carcinoma cells through down-regulation of cellular FLIP2009

    • Author(s)
      MASAYASU IWASE, SAYAKA TAKAOKA, MAKIKO UCHIDA, SAYAKA YOSHIBA, TATSUO SHIROTA, MASASHI HATORI, SATORU SHINTANI
    • Organizer
      2nd World Congress of the International Academy of Oral Oncology
    • Place of Presentation
      Toronto, Canada
    • Year and Date
      20090700

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi